Teradyne shares experienced a pronounced pullback over the past two sessions, closing at $216.31 on the most recent trading day, a 2.77% decrease from the prior session. This follows a close of $222.48 two days earlier, which itself represented a 2.78% drop. The dual-session slide amounts to a cumulative decline of 5.7%, marking the steepest two-day loss for the stock since late November.

While the S&P 500 advanced by 0.9% on the same day that Teradyne fell 2.77%, the company’s stock has underperformed the broader market by 6.5% over the last five trading days. Trading volume averaged 3.2 million shares, roughly 50% above the 30-day daily average, signaling elevated investor activity as the stock departs from its mid-year highs near $235.

Investors cite concerns over slowing capital expenditure in semiconductor test equipment, Teradyne’s core business, as a primary catalyst for the recent sell-off. Early reports from industry data provider TechInsights indicate a 4% sequential drop in global chip test capacity in Q4. Jefferies analysts have revised their growth forecast for Teradyne’s 2026 revenue to 9% year-over-year, down from a prior 12% estimate, while maintaining a 'Hold' rating and a $230 price objective.

The latest pullback has brought Teradyne’s forward price-to-earnings ratio down to 18.2x, near the five-year average of 17.8x, potentially offering a valuation entry point for long-term investors. However, uncertainty around semiconductor inventory cycles and upcoming quarterly results, scheduled for release in early February, suggests that holders should monitor order backlog trends and management commentary on end-market demand before increasing exposure.